Like Definiens

announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

Ziehm Imaging, acquired THERENVA

synopsis: Germany-based Ziehm Imaging, a developer of mobile X-ray imaging solutions, has acquired Therenva, a leading French developer of planning and imaging software tools for cardiovascular procedures. Ziehm Imaging will leverage its strong distribution network of mobile C-arms to market Therenva’s current product portfolio globally.
buyer: Ziehm Imaging
Germany-based Ziehm Imaging specializes in the development, manufacturing, and worldwide marketing of mobile X-ray-based imaging solutions. The company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. "
target: THERENVA
France-based Therenva designs the most advanced and user-friendly imaging software toolset for cardiovascular procedures. The unique EndoSize 3D case planning software has become an essential tool in the daily practice of many physicians and healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/20/2019 via BNC Analysis

Circle Cardiovascular Imaging Inc., acquired Corstem

synopsis: Circle Cardiovascular Imaging, a Canadian developer of analytical software for the cardiac imaging community, has acquired Corstem, a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables better, safer, and faster care decision.​
buyer: Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging is a Canadian developer of analytical software for the cardiac imaging community. Circle's product suite, civ42, is engineered for use in cardiac imaging and has been designed specifically to facilitate efficient quantitative evaluation of cardiac imaging studies. "
target: Corstem
Corstem is a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables a whole new level of efficiency and automation for diagnosis aid to achieve better, safer, and faster care decision.​
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$23,759.43)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via PE Hub

Imagia, acquired Cadens Medical Imaging

synopsis: Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software.
buyer: Imagia
Imagia is a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems. "
target: Cadens Medical Imaging
Cadens Medical Imaging (Cadens) is a technology leader in medical imaging software. Since 2008, Cadens has developed and marketed FDA and CE cleared innovative medical imaging software products for cancer care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/13/2015 via BusinessWire

Toshiba Medical Systems Corporation, acquired Olea Medical

synopsis: Olea Medical SA, a company that designs and markets innovative medical imaging applications, has been acquired by Toshiba Medical Systems Corporation, a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions.
buyer parent: Toshiba
buyer: Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. "
target: Olea Medical
Olea Medical™ designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2021 via GlobeNewswire

SeaSpine, acquired 7D Surgical

synopsis: SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, has acquired 7D Surgical, a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
buyer: SeaSpine (SPNE:$160.19)
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. "
target: 7D Surgical
7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
price ($mm)
$110
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

MicroSurgical Technology, Inc., acquired Neomedix Corporation

synopsis: In a move to expand its offerings into surgical glaucoma, MST has acquired the assets of NeoMedix Corporation related to glaucoma, including Trabectome and Goniotome product platforms. Trabectome is an easy to use surgical technology used to treat glaucoma, and Goniotome is an innovative solution for goniotomy
buyer parent: Halma plc
buyer: MicroSurgical Technology, Inc.
MicroSurgical Technology (MST) manufactures ophthalmic surgical products, focusing on single-use devices used in cataract surgery. MST makes precise, small tools that allow the management of delicate eye tissue or fluid. "
target: Neomedix Corporation
NeoMedix Corporation develops software and is known for its Trabectome and Goniotome products. Trabectome is an easy to use surgical technology with a clinical history of proven efficacy used to treat glaucoma. Goniotome is an easy and innovative solution for goniotomy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2014 via Company Press Release

Materialise Dental N.V., acquired OrthoView

synopsis: Materialise announced the acquisition of UK-based OrthoView Holdings Limited, the world's leading provider of 2D digital pre-operative planning and templating solutions for orthopedic surgeons. OrthoView’s software imports a digital X-ray image from a PACS and positions the templates of suitable prostheses on the X-ray image at the correct scale.
buyer: Materialise Dental N.V. (GS:MTLS:$86.16)
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis. "
target: OrthoView
OrthoView enables orthopedists to create detailed pre-operative plans quickly and easily from digital x-ray images. The OrthoView solution provides an easy to use method of planning and templating with digital x-ray images, incorporating specialist on-screen measuring tools and patented wizards.
price ($mm)
$14
rev ($mm)
$6
EBITDA ($mm)
$2
EV / rev
2.6x
EV / EBITDA
9.3x
closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2019 via BNC Analysis

Surgical Science, acquired SenseGraphics

synopsis: Surgical Science Sweden AB, a Swedish supplier of virtual reality simulators for medical training, has acquired SenseGraphics AB, a Sweden-based medical simulator software developer. SenseGraphics develops medical simulators that combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
buyer: Surgical Science (OM:SUS:$7.20)
Surgical Science is a Swedish supplier of virtual reality simulators for medical training. Their training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors. "
target: SenseGraphics
SenseGraphics is a Sweden-based medical simulator software developer. SenseGraphics develops next generation medical simulators for a wide range of surgical procedures. Their simulators combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
price ($mm)
$32
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2018 via GlobeNewswire

Globus Medical, acquired Surgimap

synopsis: Globus Medical, Inc., a leading musculoskeletal solutions company, announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software platform.
buyer: Globus Medical (GMED:$675.57)
Globus Medical, Inc. is a leading medical device manufacturer and is driving significant technological advancements across a complete suite of spinal products. "
target: Surgimap
Nemaris Inc. is a privately held company that markets and develops Surgimap®, a leading surgical planning software platform. Surgimap® allows healthcare professionals to simulate potential surgical outcomes and share medical imaging globally to improve procedural workflow and patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/19/2017 via Company Press Release

JSR Corporation, will acquire Lexi Co., Ltd.

synopsis: JSR Corporation agreed to acquire Lexi Co., Ltd., a medical 3D software company. Lexi Co., Ltd. develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data.
buyer: JSR Corporation (TSE:4185:$3,499.68)
JSR Corporation, based in Japan, was established in 1957 for domestic production of synthetic rubbers. Since then, JSR has continuously expanded its business to emulsions, plastics and other materials for the semiconductor, flat panel display, and optical materials fields. "
target: Lexi Co., Ltd.
Lexi is a Japanese company that develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data. Users can perform surgical simulations (such as positioning of implants, calculation of parameters, etc.) in simple steps.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2014 via GlobeNewswire

3D Systems Corporation, acquired Simbionix USA Corporation

synopsis: 3D Systems announced that it completed the acquisition of Simbionix, the global leader in 3D virtual reality surgical simulation and training for $120 million in cash. Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry.
buyer: 3D Systems Corporation (DDD:$617.50)
3D Systems is a leading provider of 3D printing centric design-to-manufacturing solutions including 3D printers, print materials and cloud sourced on-demand custom parts for professionals and consumers alike in materials including plastics, metals, ceramics and edibles. "
target: Simbionix USA Corporation
Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry. The company is committed to delivering the highest quality products, advancing clinical performance and optimizing procedural outcomes.
price ($mm)
$120
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2012 via PR Web

Visualization Sciences Group, acquired Amira

synopsis: Visage Imaging, Inc. announced they have signed a definitive agreement completing the sale of the Amira Division to Visualization Sciences Group. Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
buyer parent: FEI
buyer: Visualization Sciences Group
Visualization Sciences Group is the leading provider of high-performance 3D visualization toolkits and software for engineers and scientists, delivering advanced 3D software solutions for scientific data visualization, engineering and simulation, materials science and geosciences. "
target parent: Pro Medicus
target: Amira
Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2019 via PE Hub

Micromed SpA, acquired OSG bvba

synopsis: Micromed, an Italian medical device company, has acquired OSG BVBA, a Belgium-based sleep diagnostics software company strongly positioned in sleep neuromonitoring and clinical neurophysiology. With the acquisition, Micromed will gain direct access to the Benelux market, thanks to OSG’s strong position in the area.
buyer parent: ArchiMed
buyer: Micromed SpA
Micromed is an Italian medical device company delivering solutions in Neurophysiology worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, Micromed manufactures and markets neurodiagnostic hardware and software to neurologists, clinicians and researchers. "
target: OSG bvba
OSG is a Belgian developer of software products for Sleep Research and Brain Research. With their products BrainRT and SleeptRT, OSG is highly regarded in sleep neuromonitoring and clinical neurophysiology with advanced capabilities in AI as it relates to sleep scoring and data interpretation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/10/2014 via PR Newswire

Alphaeon Corporation, acquired TouchMD

synopsis: ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired TouchMD. TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates.
buyer parent: Strathspey Crown
buyer: Alphaeon Corporation
Alphaeon Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. "
target: TouchMD
TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates. They offer product lines in Plastics, OBGYN, Dermatology, and Orthopedics.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2020 via BusinessWire

RapidAI, acquired Endovantage, LLC

synopsis: RapidAI, the worldwide leader in advanced imaging for stroke, announced the acquisition of EndoVantage, developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
buyer: RapidAI
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS*. "
target: Endovantage, LLC
EndoVantage is the developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2010 via PR Newswire

Trimble Navigation Limited, acquired eCognition

synopsis: Trimble and Definiens, a company specializing in image analysis solutions, announced Trimble's acquisition of Definiens' Earth Sciences business assets, eCognition® software, an advanced image analysis software suite for geospatial applications that facilitates fast and accurate geo-information extraction from remote sensing imagery.
buyer: Trimble Navigation Limited (TRMB:$3,133.80)
Trimble applies technology to make field and mobile workers in businesses and government significantly more productive. Solutions are focused on applications requiring position or location—including surveying, construction, agriculture, fleet and asset management, public safety and mapping. "
target parent: Definiens
target: eCognition
eCognition software enables organizations to quickly extract accurate geo-information from any kind of remote sensing data. The software assists data providers, value adders and scientist in integrating earth observation and remote sensing data to generate accurate GIS-ready information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via GlobeNewswire

Syneos Health, acquired StudyKIK

synopsis: Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
buyer: Syneos Health (SYNH:$4,730.38)
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. "
target: StudyKIK
StudyKIK is a leading technology-enabled clinical trial recruitment and retention company. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2021 via GlobeNewswire

Green Shield, acquired Tranquility Online

synopsis: The Green Shield Canada (GSC) group of companies is pleased to announce its acquisition of Tranquility Online, a rapidly growing mental health platform specializing in internet-based cognitive behavioral therapy (iCBT) and mental health coaching.
buyer: Green Shield
Green Shield Canada is Canada’s fourth-largest health and dental benefits provider, and is uniquely structured as a social enterprise with the purpose of making it easier for people to live their healthiest lives. They are Canada’s only not-for-profit health and dental benefits provider. "
target: Tranquility Online
Tranquility Online is a rapidly growing mental health platform specializing in internet-based cognitive behavioral therapy (iCBT) and mental health coaching. They are based in Halifax, Nova Scotia.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2021 via PR Newswire

Sharecare, Inc., acquired CareLinx

synopsis: Sharecare, the digital health company that helps people manage all their health in one place, has closed its acquisition of CareLinx, the nation's leading digital on-demand platform of tech-enabled care providers.
buyer: Sharecare, Inc. (NasdaqGS:SHCR:$331.76)
Sharecare is the digital health company that helps people manage all their health in one place. The Sharecare platform provides each person with a comprehensive and personalized health profile where they can dynamically and easily connect to the information. "
target parent: The Generali Group
target: CareLinx
CareLinx is a leading nationwide, tech-enabled caregiver marketplace improving access to affordable, quality home care for families, large health systems, and insurance companies. CareLinx caregivers leverage proprietary digital care plans to better assist the elderly and disabled.
price ($mm)
$65
rev ($mm)
$5
EBITDA ($mm)
EV / rev
13.0x
EV / EBITDA
closed 7/28/2021 via GlobeNewswire

Aquiline Capital Partners, acquired Avera eCARE

synopsis: Avera Health announced the acquisition of its telemedicine services, Avera eCare, by Aquiline Capital Partners, a private investment firm based in New York and London. As part of the acquisition, Aquiline will execute the carve-out of Avera eCare and rename the company Avel eCare.
buyer: Aquiline Capital Partners
Aquiline Capital Partners, founded in 2005, is a private investment firm based in New York and London investing in businesses across financial services and technology, business services, and healthcare. The firm had $6.4 billion in assets under management as of March 31, 2021. "
target parent: Avera Health
target: Avera eCARE
Avera eCARE, who will rename as Avel eCare, offers one of the largest and most comprehensive virtual health networks in the world – partnering with more than 600 health care systems, rural hospitals, outpatient clinics, long-term care facilities, assisted livings, and schools across the country.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/10/2021 via BusinessWire

NeuPath, will acquire KumoCare, Inc.

synopsis: Ontario-based NeuPath Health Inc., owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, will acquire KumoCare, a Canadian virtual care platform. The acquisition will further expand NeuPath’s virtual care and telemedicine offerings.
buyer: NeuPath (TSXV:NPTH:$41.24)
Based in Ontario, NeuPath is a vertically integrated health care provider utilizing research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by chronic pain, spinal injuries, sport-related injuries, and concussions. "
target: KumoCare, Inc.
Based in Canada, KumoCare is a telemedicine platform that uses mobile and cloud technology to enable patients to connect with health care providers from their homes. Through its mobile app, KumoCare provides easy and affordable access to professional and affordable health care.
price ($mm)
$1.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via GlobeNewswire

Patient Access Solutions, Inc., acquired Tela Mental Health

synopsis: Patient Access Solutions (PASO), a provider of healthcare/financial processing and management solutions for the healthcare industry, has acquired Tela Mental Health. This acquisition will allow PASO to offer mental health services through the telamentalhealth.com portal, connecting patients to psychologists, psychiatrists and therapists nationwide.
buyer parent: Global Energy Resources, Inc
buyer: Patient Access Solutions, Inc. (OTCPK:PASO:$1.82)
Patient Access Solutions Inc. is a Healthcare Solutions company with its sights set on shaking up a stodgy healthcare information technology industry. Paying little respect to tradition in a business rooted in tradition, PASHealth has created a formidable array of technologyand resources. "
target: Tela Mental Health
Tela Mental Health is an American healthcare institution, specializing in mental health. Tela Mental Health is focused on mental wellness for patients accessing their care provider remotely and the demand for this is high.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/4/2021 via BusinessWire

Carbon Health, acquired Steady

synopsis: Carbon Health, a leading technology-enabled healthcare provider, has acquired Steady Health, a fully integrated diabetes platform that uses data from continuous glucose monitoring (CGM) devices to provide personalized medical care from top endocrinologists. The acquisition will accelerate the rollout of Carbon Health's new primary care model.
buyer: Carbon Health
Carbon Health is a leading national healthcare provider with a mission to bring high-quality healthcare to everyone. Leveraging its unique technology platform, Carbon Health provides its patients with omnichannel care: seamless care from the same trusted providers at a wide variety of access points."
target: Steady
Steady Health is a fully integrated diabetes platform that uses data from continuous glucose monitoring devices (CGM) to provide personalized medical care. Through its platform, users can receive real-time coaching from specialists based on personal insights from CGMs to achieve meaningful goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/27/2021 via BNC Analysis

TeleMed2U, acquired Medzino United States

synopsis: Medzino, an Austin-based startup specializing in telemedicine and mail order pharmacy, announced that their US brand will be acquired by TeleMed2U, a leading telemedicine company operating out of Austin, Texas and Roseville, California. Medzino is a digital health brand offering online diagnosis, prescriptions by U.S. certified physicians.
buyer parent: Kura MD
buyer: TeleMed2U
Telemed2U is a multi-specialty technology-enabled services company that supplies its clients with real-time access to physician specialists through the use of secure state-of-the-art, audio-visual technology. "
target: Medzino United States
Medzino is an Austin-based digital health brand offering online diagnosis, prescriptions by U.S. certified physicians, and home delivery of medication across 38 US states. Following a short two-minute online consultation, patients are able to request treatment for a range of primary care issues.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/23/2021 via GlobeNewswire

Accolade, Inc., will acquire PlushCare

synopsis: Accolade, Inc., the company reinventing healthcare by helping people live their healthiest lives, will acquire PlushCare, a leading provider of virtual primary care and mental health treatment. With the acquisition, Accolade will begin offering virtual primary care and mental health consultations directly to members.
buyer: Accolade, Inc. (:$155.57)
Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade connects personal health data and programs to present a single point of entry to health and benefits resources while coordinating with providers. "
target: PlushCare
PlushCare is a leading virtual primary care and mental health platform that offers virtual doctor visits to patients in all 50 U.S. states. Patients are connected to the best physicians trained at a top 50 medical institution in the U.S. via desktop or mobile devices.
price ($mm)
$380
rev ($mm)
$35
EBITDA ($mm)
EV / rev
12.9x
EV / EBITDA
closed 4/12/2021 via BNC Analysis

HealthHero, acquired QARE

synopsis: HealthHero, the highly acquisitive London-based healthcare company, has acquired French telemedicine provider Qare. Qare has seen 800% growth in users in 2020 as Covid-19 caused doctors surgeries to shift to online consultations.
buyer parent: MARCOL
buyer: HealthHero
HealthHero is a European digital health company. HealthHero provides provide virtual access to doctors and expert clinicians to give patients the advice they need. They allow patients to tap into medical services 24/7 through video calls, online chats or phone calls. "
target parent: Kamet
target: QARE
Qare is a French telemedicine provider that allows patients to choose a practitioner from over 30 specialties available online. Qare has seen 800% growth in users in 2020 as Covid-19 caused doctors surgeries to shift to online consultations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/17/2021 via BusinessWire

Doctor On Demand will be merged with Grand Rounds,

synopsis: Doctor On Demand, the nation’s leading virtual care provider, will merge with Grand Rounds, a leader in healthcare quality and navigation. These two premier platforms will offer an unmatched patient and provider experience, providing a full suite of digital and interactive solutions to help address the problem of uncoordinated care in the U.S.
buyer: Grand Rounds
Grand Rounds is a new kind of healthcare company with a mission to raise the standard of healthcare for everyone, everywhere. The Grand Rounds team goes above and beyond to connect and guide people to the highest quality healthcare available for themselves and their loved ones. "
target: Doctor On Demand
Doctor On Demand is the nation’s leading virtual care provider. The company's full suite of personalized Total Virtual Care services include primary care, integrated behavioral health, everyday and urgent care, chronic condition management, and prevention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2021 via BNC Analysis

True Incube, acquired Chiiwii

synopsis: True Incube, a tech incubator based in Thailand, has acquired a 60.72% stake in Chiiwii, a mobile telemedicine service in Thailand. Chiiwii provides patients with accessible health consultation services at anytime and anywhere. Their platform offers specialists for child health, women's health, skin care, mental health, and other health concerns.
buyer parent: True Corporation Public Company Limited
buyer: True Incube
True Incube is a tech incubator based in Thailand. True Incube provides support and opportunities to startups that want to take their businesses to the next level. The firm provides their services to startups in various sectors, including adtech, agritech, deep tech, IoT, e-commerce and more. "
target: Chiiwii
Chiiwii is a mobile telemedicine service in Thailand. Chiiwii provides patients with accessible health consultation services at anytime and anywhere. Their platform offers specialists for child health, women's health, skin care, mental health, internal medicine, and other health concerns.
price ($mm)
$1.58*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/20/2021 via GlobeNewswire

Victory Square Technologies, will acquire Hydreight

synopsis: Canada-based Victory Square Technologies Inc. will acquire IV Hydreight Inc., a mobile health and wellness service provider operating in the United States. Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.
buyer: Victory Square Technologies (CNSX:BZ30197:$1.15)
Canada-based Victory Square builds, acquires, and invests in startups, then provides the senior leadership and resources needed to fast-track growth. Its portfolio consists of 20 global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health, and gaming."
target: Hydreight
Hydreight is a mobile health and wellness service provider. The company provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office, or wherever they may need discreet assistance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/13/2021 via BNC Analysis

HealthHero, acquired MyClinic

synopsis: HealthHero, a European digital health company, has acquired MyClinic, a holistic telehealth service in Ireland. MyClinic offers convenient, discreet and affordable healthcare to patients in Ireland. Their platform provides access to secure online video consultations with a wide range of healthcare professionals.
buyer parent: MARCOL
buyer: HealthHero
HealthHero is a European digital health company. HealthHero provides provide virtual access to doctors and expert clinicians to give patients the advice they need. They allow patients to tap into medical services 24/7 through video calls, online chats or phone calls. "
target: MyClinic
MyClinic is a holistic telehealth service in Ireland. MyClinic offers convenient, discreet and affordable healthcare to patients in Ireland. Their platform provides access to secure online video consultations with a wide range of healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/24/2020 via BusinessWire

UpHealth Inc. will be merged with GigCapital, Inc.,

synopsis: GigCapital2, a Technology, Media and Telecom (TMT) Private-to-Public Equity (PPE)™ corporation, announced that it has entered into a business combination agreement with UpHealth, one of the largest national and international digital healthcare providers.
buyer: GigCapital, Inc. (:KLR.ASE:$0.00)
GigCapital is a Private-to-Public Equity technology, media, and telecommunications (TMT) focused investment group. The group deploys a unique Mentor-Investors methodology to partner with exceptional TMT companies, managed by dedicated and experienced entrepreneurs. "
target: UpHealth Inc.
UpHealth is a global comprehensive digital health technology and tech-enabled services platform that empowers providers, health systems and payors globally to manage care for people with complex medical, behavioral and social needs, while dramatically improving access to primary care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/12/2020 via BusinessWire

Talkspace, acquired Lasting

synopsis: Talkspace has acquired Lasting, the leading relationship counseling app, in the latest move on behalf of the company’s ongoing commitment to expand the telebehavioral health services available on the Talkspace platform. Lasting provides convenient, affordable access to resources to support couples and tailors content to their unique needs.
buyer: Talkspace
Talkspace is a telebehavioral healthcare company. Its signature psychotherapy product connects individual users with a network of thousands of licensed therapists through an easy-to-use and HIPAA-compliant web and mobile platform. "
target parent: The Knot Worldwide
target: Lasting
Lasting, the nation's No. 1 relationship counseling app, provides couples with easy access to marriage health resources. The company's first product is a simple, app-based program that helps couples build healthier, happier marriages in a few minutes a day.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/22/2020 via BusinessWire

Transcarent merged with BridgeHealth,

synopsis: Transcarent, a consumer digital health company, has merged with BridgeHealth, the industry-leading provider of surgical advocacy and centers of excellence programs for large, self-insured organizations. BridgeHealth will introduce new high-touch, high-tech navigation services and solutions built using the Transcarent technology stack.
buyer: BridgeHealth
BridgeHealth is a provider of value-based healthcare services that guide members to surgical Centers of Excellence nationwide. Its bundled rates allow self-insured group health plans to improve the quality and outcomes of surgery while reducing costs from 30% to 50% on average per procedure. "
target: Transcarent
Transcarent is a consumer digital health company that uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2020 via BNC Analysis

Doctor Ryadom, acquired Doc+

synopsis: The digital medical service Doctor Ryadom, part of the VEB Ventures portfolio of projects, and the telemedicine company DOC + have announced a merger. Doc+ is a Russian provider of telemedicine and home doctor services. Their app provides patients with quick and affordable services.
buyer: Doctor Ryadom
Doctor Ryadom is a clinic chain of family medicine, specializing in ambulatory medical care. There are 11 clinics of Doctor Ryadom, located in the suburbs of Moscow. In 2017 Doctor Ryadom became one of the first Russian clinics to offer telemedicine services to customers. "
target: Doc+
Doc+ is a Russian provider of telemedicine and home doctor services. Their app provides patients with quick and affordable services for when they need them. Doc+ has provided more than 75,000 home visits and more than 20,000 teleconsultations to patients in Russia.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2020 via Company Press Release

HealthHero, acquired Fernarzt

synopsis: HealthHero, a European digital health company, has acquired Fernarzt from Heartbeat Labs, a digital health platform based in Berlin. Fernarzt is a German telemedicine platform that connects doctors to patients. Fernarzt provides consulting services for general, sexual, and skin & hair health issues.
buyer parent: MARCOL
buyer: HealthHero
HealthHero is a European digital health company. HealthHero provides provide virtual access to doctors and expert clinicians to give patients the advice they need. They allow patients to tap into medical services 24/7 through video calls, online chats or phone calls. "
target parent: Heartbeat Labs
target: Fernarzt
Fernarzt is a German telemedicine platform that connects doctors to patients. Fernarzt provides consulting services for general, sexual, and skin & hair health issues. Their network of doctors provides patients with prescriptions that can either be sent to an online pharmacy or to their home.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA

Like Definiens


read more

Definiens

THERENVA

Corstem

EPD Solutions Ltd.

Cadens Medical Imaging

imorphics

Olea Medical

7D Surgical

Neomedix Corporation

OrthoView

Transpire, Inc.

SenseGraphics

MST Medical Surgery Technologies Ltd.

Surgimap

Lexi Co., Ltd.

Simbionix USA Corporation

Amira

OSG bvba

TouchMD

Endovantage, LLC

read more

Definiens

eCognition

read more

Definiens

read more

StudyKIK

Tranquility Online

CareLinx

Avera eCARE

KumoCare, Inc.

Tela Mental Health

Steady

Medzino United States

PlushCare

QARE

Doctor On Demand

Chiiwii

Hydreight

MyClinic

UpHealth Inc.

Lasting

Transcarent

Doc+

Fernarzt

Livongo

Geography
Matching Companies
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: GS:MTLS
 
 
 
 
 
 
 
 
Materialise Dental N.V.
Materialise Dental N.V.
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis.
year
2014
rev ($mm)
$86.16
EBITDA ($mm)
$5.18
EBIT ($mm)
$0.35
Net Income ($mm)
$2.18
Employees
958
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: NMXS
 
 
 
 
 
 
 
 
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments.
year
2011
rev ($mm)
$3.21
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.21)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,552.99
EBITDA ($mm)
$1,247.29
EBIT ($mm)
$792.06
Net Income ($mm)
$792.91
Employees
27400
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: ICAD
 
 
 
 
 
 
 
 
iCAD, Inc.
iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster. iCAD offers a range of computer aided detection (CAD) solutions to support rapid detection of breast, prostate and colorectal cancers.
year
2015
rev ($mm)
$47.24
EBITDA ($mm)
$5.53
EBIT ($mm)
$1.33
Net Income ($mm)
Employees
143
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: LSE:AZN
 
 
 
 
 
 
 
 
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
year
2016
rev ($mm)
$24,062.00
EBITDA ($mm)
$5,495.00
EBIT ($mm)
$3,388.00
Net Income ($mm)
$2,221.00
Employees
61500
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: ENDP
 
 
 
 
 
 
 
 
Endo Health Solutions Inc.
Endo Health Solutions Inc. is a US-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology.
year
2013
rev ($mm)
$3,027.36
EBITDA ($mm)
$1,075.86
EBIT ($mm)
$790.34
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: PGNX
 
 
 
 
 
 
 
 
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer.
year
2015
rev ($mm)
$43.27
EBITDA ($mm)
($0.54)
EBIT ($mm)
($1.07)
Net Income ($mm)
$2.85
Employees
57
  • drill down
  • watch
Ticker: LSE:PRTC
 
 
 
 
 
 
 
 
PureTech Health
PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and more.
year
2019
rev ($mm)
$9.81
EBITDA ($mm)
($132.05)
EBIT ($mm)
($135.40)
Net Income ($mm)
$421.14
Employees
300
  • drill down
  • watch
Ticker: BSE:531637
 
 
 
 
 
 
 
 
Sword and Shield Pharma Ltd.
Sword and Shield Pharma Ltd.
Sword & Shield Pharma is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. They offer a portfolio of products including Active Pharmaceutical Ingredients, generics, differentiated formulations and News Chemical Entities.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CNC
 
 
 
 
 
 
 
 
Centene Corporation
Centene Corporation
Centene Corporation is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. Centene Corporation provides affordable and high-quality healthcare services to members in all 50 states and around the world.
year
2020
rev ($mm)
$95,748.00
EBITDA ($mm)
$5,331.00
EBIT ($mm)
$4,247.00
Net Income ($mm)
$2,029.00
Employees
56600
  • drill down
  • watch